Savara

SVRANasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.195 B

$5.83 +0.69%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$118.8M

Loss-making

Shares outstanding

204,657,499

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#150Eton PharmaceuticalsETON$1.22B
#151Wave Life SciencesWVE$1.20B
#152SavaraSVRA$1.19B
#153Corvus PharmaceuticalsCRVS$1.17B
#154InventivaIVA$1.13B

Where these numbers come from

Share counts and financials for Savara are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.